IN2014MU01178A - - Google Patents

Info

Publication number
IN2014MU01178A
IN2014MU01178A IN1178MU2014A IN2014MU01178A IN 2014MU01178 A IN2014MU01178 A IN 2014MU01178A IN 1178MU2014 A IN1178MU2014 A IN 1178MU2014A IN 2014MU01178 A IN2014MU01178 A IN 2014MU01178A
Authority
IN
India
Prior art keywords
salts
methyldopa
relates
present
oral bioavailability
Prior art date
Application number
Other languages
English (en)
Inventor
Pankaj Trimbak Adsare
Vijay Suggala
Kapileswar Swain
Yatendra Kumar
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN1178MU2014 priority Critical patent/IN2014MU01178A/en
Priority to PCT/IB2015/052016 priority patent/WO2015150959A1/en
Publication of IN2014MU01178A publication Critical patent/IN2014MU01178A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1178MU2014 2014-03-29 2015-03-19 IN2014MU01178A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN1178MU2014 IN2014MU01178A (es) 2014-03-29 2015-03-19
PCT/IB2015/052016 WO2015150959A1 (en) 2014-03-29 2015-03-19 Oral liquid pharmaceutical compositions comprising methyldopa or salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1178MU2014 IN2014MU01178A (es) 2014-03-29 2015-03-19

Publications (1)

Publication Number Publication Date
IN2014MU01178A true IN2014MU01178A (es) 2015-10-02

Family

ID=54395493

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1178MU2014 IN2014MU01178A (es) 2014-03-29 2015-03-19

Country Status (1)

Country Link
IN (1) IN2014MU01178A (es)

Similar Documents

Publication Publication Date Title
PH12017500281A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
EA201692280A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA033544B1 (ru) Производные пиридона в качестве ингибиторов киназы, реаранжированной во время трансфекции (ret)
MD4820C1 (ro) Compuşi dihidroizochinolinonici substituiţi
MX2017008518A (es) Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih).
NZ729037A (en) Carboxylic acid compound, method for preparation thereof, and use thereof
TW201613864A (en) Novel compounds
MA39765A (fr) Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
EA201691741A1 (ru) Фармацевтическая композиция
MX359887B (es) Composicion masticable para administracion oral y proceso para preparar la misma.
EA201791397A1 (ru) СВЯЗАННЫЕ С ГЕТЕРОЦИКЛИЛАМИ ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ
EA201991286A1 (ru) Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин
PH12017500323A1 (en) P38 map kinase inhibiting indanyl urea compounds
IN2014MU01178A (es)
IN2014MU01179A (es)
PH12016502527B1 (en) Stabilized desmopressin
EA033077B1 (ru) Фармацевтическая композиция, содержащая 13 глицеридов, и ее препараты и их применение
PH12018500946A1 (en) Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof
MX2016011522A (es) Composicion farmaceutica de esomeprazol con bicarbonato de sodio en el proceso de preparacion de una capsula, para el tratamiento de alopatias relacionadas con la acidez gastrica.
IN2013MU01152A (es)
EA201500090A1 (ru) Фармацевтическая композиция, содержащая силденафила цитрат, и способ ее приготовления
MX2014008984A (es) Proceso de obtencion y composicion farmaceutica de fenofibrato capsulas como agente regulador de lipidos para su administracion oral.
GR1008804B (el) Συνθεσεις για ιατρικη χρηση οι οποιες περιλαμβανουν υαλουρονικο οξυ ή αλατα αυτου, αμινοξεα, βιταμινες, ανοργανα αλατα και αλλα συστατικα